Asiatic Laboratories Limited (DSE:ASIATICLAB)

Market Cap	5.85B
Revenue (ttm)	2.24B
Net Income (ttm)	378.08M
Shares Out	122.39M
EPS (ttm)	3.09
PE Ratio	15.47
Forward PE	n/a
Dividend	1.00 (2.09%)
Ex-Dividend Date	Nov 23, 2025

Volume	387,706
Average Volume	916,510
Open	48.60
Previous Close	47.80
Day's Range	47.30 - 48.60
52-Week Range	29.00 - 65.00
Beta	n/a
RSI	37.82
Earnings Date	Feb 9, 2026

About Asiatic Laboratories

Asiatic Laboratories Limited manufactures and markets pharmaceutical products in Bangladesh and internationally. The company offers products in the categories of antihistamines and respiratory care; cardiac and eye care; antibiotics, antifungals and antiprotozoals; vitamins and minerals; antiulcerants and antiemetics; dermatological products; antipsychotics and tranquilizers; and non-steroidal anti-inflammatory drugs. It distributes its products through sales distribution centers and a store. The company also exports its products. Asiatic Labor...

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 777
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ASIATICLAB

Financial Performance

In 2025, Asiatic Laboratories's revenue was 1.77 billion, an increase of 27.45% compared to the previous year's 1.39 billion. Earnings were 255.36 million, a decrease of -8.30%.